In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein.
We recently identified and purified a novel human kallikrein-binding protein (HKBP) from human plasma. The HKBP forms a 92 kd sodium dodecyl sulfate-stable and heat-stable complex with tissue kallikrein. This study was undertaken to characterize the plasma clearance and tissue distribution of exogenously administered HKBP and its complex with tissue kallikrein. Human tissue kallikrein was first incubated with purified HKBP, and the high-molecular-weight complex was separated from unbound proteins on a high-pressure liquid chromatography gel filtration column. Tissue kallikrein, kallikrein-binding protein, and their complex were labeled with iodine-125 and then injected intravenously into Sprague-Dawley rats. The disappearance rates of trichloracetic acid-precipitable radioactivity from the circulation were determined. The clearance profile of HKBP shows a nonlinear pattern with an apparent half-life of 65 minutes (n = 4). The plasma clearance of HKBP complexed with kallikrein shows a similar profile but a shorter half-life of 33 minutes (n = 3). HKBP and its complex with kallikrein were mainly taken up by the liver but to a lesser degree by the kidney, lung, and other tissues. Labeled human kallikrein has an apparent half-life of 8 minutes (n = 4), and its clearance consists of a fast and a slow component. The data indicate that kallikrein-HKBP complex is cleared from the circulation two times faster than that of the binding protein alone and that it persists in the circulation four times longer than kallikrein alone. The results support the notion that more than one pathway exists for the metabolism of tissue kallikrein and that HKBP plays a role in modulating tissue kallikrein's bioavailability.
Xiong
W
W
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston 29425.
Tang
C Q
CQ
Zhou
G X
GX
Chao
L
L
Chao
J
J
D000818:Animals; D002352:Carrier Proteins / Q000378:metabolism* / Q000493:pharmacokinetics; D006801:Humans; D007610:Kallikreins / Q000378:metabolism* / Q000493:pharmacokinetics; D046911:Macromolecular Substances; D008657:Metabolic Clearance Rate; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains; D015843:Serpins / Q000378:metabolism* / Q000493:pharmacokinetics; D014018:Tissue Distribution
D002352:Carrier Proteins; D046911:Macromolecular Substances; D015843:Serpins; C051324:kallistatin; D007610:Kallikreins